Irvine, CA, United States of America

Jinfa Du



Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Athens, GA (US) (1996 - 1997)
  • Irvine, CA (US) (2000 - 2005)

Company Filing History:


Years Active: 1996-2005

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jinfa Du

Introduction

Jinfa Du is a prominent inventor based in Irvine, California, known for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he has made remarkable advancements in drug development and therapeutic applications.

Latest Patents

Among his latest patents, Jinfa Du has developed therapeutic azide compounds that enhance the efficacy of pharmaceutical prodrugs. These compositions comprise azide derivatives of drugs that can be converted to the active drug in vivo, thereby increasing their half-life. Notably, these azide prodrugs demonstrate improved ability to penetrate the blood-brain barrier compared to their corresponding drugs. His work includes azide derivatives of various therapeutic agents, such as cordycepin and acyclovir. Additionally, he has created a novel process for preparing 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine, which exhibits potent anti-viral activity against hepatitis B and Epstein-Barr viruses.

Career Highlights

Jinfa Du has had a distinguished career, contributing to various research initiatives and projects. He has worked with the University of Georgia Research Foundation, Inc., where he has furthered his research in pharmaceutical sciences.

Collaborations

Throughout his career, Jinfa Du has collaborated with notable professionals in the field, including Chung K Chu and Raymond F Schinazi. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Jinfa Du's work exemplifies the intersection of innovation and pharmaceutical development. His contributions continue to influence the field, paving the way for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…